Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 50 results in range #48,051 to #48,100.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Almotriptan drug interactions (3 revisions)
  2. Almotriptan indications and usage (3 revisions)
  3. Almotriptan labels and packages (3 revisions)
  4. Almotriptan use in specific populations (3 revisions)
  5. Aloe vera (3 revisions)
  6. Alopecia case study one (3 revisions)
  7. Alopecia echocardiography and ultrasound (3 revisions)
  8. Alopecia totalis (3 revisions)
  9. Alopecia x ray (3 revisions)
  10. Alpha-1-microglobulin/bikunin precursor (3 revisions)
  11. Alpha-1D adrenergic receptor (3 revisions)
  12. Alpha-2-Macroglobulin (3 revisions)
  13. Alpha-GPC (3 revisions)
  14. Alpha-tocopherol transfer protein (3 revisions)
  15. Alpha 1-antitrypsin (3 revisions)
  16. Alpha 1-antitrypsin deficiency echocardiography or ultrasound (3 revisions)
  17. Alpha 2-antiplasmin (3 revisions)
  18. Alport syndrome epidemiology and demographics (3 revisions)
  19. Alport syndrome historical perspective (3 revisions)
  20. Alport syndrome overview (3 revisions)
  21. Alprazolam contraindications (3 revisions)
  22. Alstrom syndrome case study one (3 revisions)
  23. Alternate hypothesis (3 revisions)
  24. Altitude sickness case study one (3 revisions)
  25. Altitude sickness diagnostic study of choice (3 revisions)
  26. Alveolate (3 revisions)
  27. Alveolitis (3 revisions)
  28. Alverine (3 revisions)
  29. Amantadine drug interactions (3 revisions)
  30. Amanullin (3 revisions)
  31. Amaurosis fugax differential diagnosis (3 revisions)
  32. Amaurosis fugax medical therapy (3 revisions)
  33. Amaurosis fugax pathophysiology (3 revisions)
  34. Ambulatory Patient Group (3 revisions)
  35. Amelia (birth defect) (3 revisions)
  36. Ameloblastin (3 revisions)
  37. Ameloblastoma case study one (3 revisions)
  38. Ameloblastoma cost-effectiveness of therapy (3 revisions)
  39. Ameloblastoma electrocardiogram (3 revisions)
  40. Ameloblastoma future or investigational therapies (3 revisions)
  41. American Academy of Neurology (3 revisions)
  42. American Society for Surgery of the Hand (3 revisions)
  43. Amezinium metilsulfate (3 revisions)
  44. Amfepramone (3 revisions)
  45. Amidorphin (3 revisions)
  46. Amikacin contraindications (3 revisions)
  47. Amikacin dosage and administration (3 revisions)
  48. Amikacin indications and usage (3 revisions)
  49. Amineptine (3 revisions)
  50. Amino acid neurotransmitter (3 revisions)

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://www.wikidoc.org/index.php/Special:FewestRevisions"